Xencor (XNCR) Minority Interest (2023 - 2024)
Xencor (XNCR) reported Minority Interest of -$3.6 million for Q4 2024, down 1163.8% year-over-year from $337000.0 in Q1 2024, and down 22.02% quarter-over-quarter from -$2.9 million in Q3 2024.
Xencor (XNCR) Minority Interest (2023 - 2024) Analysis & Trends
Xencor (XNCR) has 2 years of Minority Interest data on file, last reported at -$3.6 million in Q4 2024.
- Minority Interest for Q4 2024 came in at -$3.6 million, down 1163.8% year-over-year; the trailing twelve-month figure through Dec 2024 was -$3.6 million (down 1163.8% YoY), and the FY2024 annual result was -$3.6 million, down 1163.8% from the prior year.
- Minority Interest slipped to -$3.6 million in Q4 2024 per XNCR's latest filing, from -$2.9 million in the prior quarter.
- Over five years, Minority Interest peaked at $337000.0 in Q4 2023 and troughed at -$3.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -3.59 Mn |
| Sep 30, 2024 | -2.94 Mn |
| Jun 30, 2024 | -1.78 Mn |
| Mar 31, 2024 | -339,000.00 |
| Dec 31, 2023 | 337,000.00 |